Nine patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
4
Ending by 2030
Jan 2027
Next term end
6
Patent families
When these terms end
Each bar runs from grant to computed term end. 2009 to 2041.20162023203020372041
4 pending applications: term is not computable until grant.Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2028 · High confidence
Also notable
Ends Jan 2027 · High confidence
Also notable
Ends May 2027 · High confidence
Percutaneous Mitral Valve Annuloplasty Device Delivery Method
US 8,182,529
The most cited patent in this portfolio, cited by 401 later US patents, top 1% of utility patents granted in 2012 in our data. Protection runs to 2028.
Method of Making a Tissue Shaping Device
US 7,814,635
Cited by 73 later US patents, top 10% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Mitral Valve Annuloplasty Device with Vena Cava Anchor
US 7,503,932
Cited by 49 later US patents, top 25% of utility patents granted in 2009 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 27, 2027The maintenance fee for Methods and Devices for Reducing Paravalvular Leakage (US 10,390,953) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
- 1 fee due Jun 24, 2027The maintenance fee for Sizing Catheters (US 10,512,756) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Methods and Devices for Reducing Paravalvular Leakage | 2 in force | to Oct 2037 |
| Sizing Catheters | 2 in force | to Jul 2037 |
| Percutaneous Mitral Valve Annuloplasty Device Delivery Method | 2 in force | to Apr 2028 |
| Modular Pre-Loaded Medical Implants and Delivery Systems | 1 in force | to Dec 2041 |
| Mitral Valve Annuloplasty Device with Vena Cava Anchor | 1 in force | to May 2027 |
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,814,635 | Method of Making a Tissue Shaping Device In force · High confidence | In force | High confidence | |
| US 7,503,932 | Mitral Valve Annuloplasty Device with Vena Cava Anchor In force · High confidence | In force | High confidence | |
| US 7,837,729 | Percutaneous Mitral Valve Annuloplasty Delivery System In force · Medium confidence | In force | Medium confidence | |
| US 8,182,529 | Percutaneous Mitral Valve Annuloplasty Device Delivery Method In force · High confidence | In force | High confidence | |
| US 11,400,256 | Sizing Catheters In force · High confidence | In force | High confidence | |
| US 10,512,756 | Sizing Catheters In force · High confidence | In force | High confidence | |
| US 10,390,953 | Methods and Devices for Reducing Paravalvular Leakage In force · High confidence | In force | High confidence | |
| US 11,399,939 | Methods and Devices for Reducing Paravalvular Leakage In force · High confidence | In force | High confidence | |
| US 11,596,771 | Modular Pre-Loaded Medical Implants and Delivery Systems In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 67 patents ended · 4 applications pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.